Alvéolite neutrophilique due à la minocycline ? = Minocycline-induced neutrophilic alveolitis?HAMMERER, V; FOURGAUT, G; GRONIER, O et al.Revue de pneumologie clinique (Paris). 2004, Vol 60, Num 1, pp 46-49, issn 0761-8417, 4 p.Article

Proteomic analysis of the anti-inflammatory action of minocyclineDUNSTON, Christopher R; GRIFFITHS, Helen R; LAMBERT, Peter A et al.Proteomics (Weinheim. Print). 2011, Vol 11, Num 1, pp 42-51, issn 1615-9853, 10 p.Article

Hydrogen peroxide attenuates insulin-like growth factor-1 neuroprotective effect, prevented by minocyclineJIN ZHONG; LEE, Wei-Hua.Neurochemistry international. 2007, Vol 51, Num 6-7, pp 398-404, issn 0197-0186, 7 p.Article

Injectable polysaccharide microcapsules for prolonged release of minocycline for the treatment of periodontitisYOON JEONG PARK; JUE YEON LEE; HEY RI YEOM et al.Biotechnology letters. 2005, Vol 27, Num 22, pp 1761-1766, issn 0141-5492, 6 p.Article

Lack of evidence of direct mitochondrial involvement in the neuroprotective effect of minocyclineCORNET, Sylvie; SPINNEWYN, Brigitte; DELAFLOTTE, Sylvie et al.European journal of pharmacology. 2004, Vol 505, Num 1-3, pp 111-119, issn 0014-2999, 9 p.Article

Prospects for Minocycline NeuroprotectionPLANE, Jennifer M; YAN SHEN; PLEASURE, David E et al.Archives of neurology (Chicago). 2010, Vol 67, Num 12, pp 1442-1448, issn 0003-9942, 7 p.Article

Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocyclineBOYETTE-DAVIS, J; DOUGHERTY, P. M.Experimental neurology (Print). 2011, Vol 229, Num 2, pp 353-357, issn 0014-4886, 5 p.Article

Minocycline-induced skin and dental pigmentationsMOZAFFAR, Tahseen; GORDON, Paul H.Neurology. 2006, Vol 67, Num 12, pp 2185-2185, issn 0028-3878, 1 p.Article

Minocycline 1-Year Therapy in Multiple-System-Atrophy: Effect on Clinical Symptoms and [¹¹C] (R)-PK11195 PET (MEMSA-Trial)DODEL, Richard; SPOTTKE, Annika; GASSER, Thomas et al.Movement disorders. 2010, Vol 25, Num 1, pp 97-107, issn 0885-3185, 11 p.Article

Minocycline effect on meibomian gland lipids in meibomianitis patientsSHINE, W. E; MCCULLEY, J. P; PANDYA, A. G et al.Experimental eye research. 2003, Vol 76, Num 4, pp 417-420, issn 0014-4835, 4 p.Article

Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophreniaLEVKOVITZ, Yechiel; LEVI, Uri; BROW, Yoram et al.Brain research. 2007, Vol 1154, pp 154-162, issn 0006-8993, 9 p.Article

Minocycline does not affect amyloid β phagocytosis by human microglial cellsFAMILIAN, Atoosa; EIKELENBOOM, Piet; VEERHUIS, Robert et al.Neuroscience letters. 2007, Vol 416, Num 1, pp 87-91, issn 0304-3940, 5 p.Article

Improved LC of minocycline drug substanceZAWILLA, N. H; DIANA, J; HOOGMARTENS, J et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 40, Num 4, pp 815-821, issn 0731-7085, 7 p.Article

MINOCYCLINE INHIBITS D-AMPHETAMINE-ELICITED ACTION POTENTIAL BURSTS IN A CENTRAL SNAIL NEURONCHEN, Y.-H; LIN, P.-L; WONG, R.-W et al.Neuroscience. 2012, Vol 223, pp 412-428, issn 0306-4522, 17 p.Article

The British Medical Journal and prescribing of minocycline for acneMOSS, C; FERNER, R. E.British journal of dermatology (1951). 2013, Vol 168, Num 3, pp 667-668, issn 0007-0963, 2 p.Article

Minocycline-Induced Fulminant Intracranial HypertensionFRASER, Clare L; BIOUSSE, Valerie; NEWMAN, Nancy J et al.Archives of neurology (Chicago). 2012, Vol 69, Num 8, pp 1067-1070, issn 0003-9942, 4 p.Article

Randomized trial of minocycline in the treatment of HIV-associated cognitive impairmentNAKASUJJA, Noeline; MIYAHARA, Sachiko; EVANS, Scott et al.Neurology. 2013, Vol 80, Num 2, pp 196-202, issn 0028-3878, 7 p.Article

Minocycline treatment for HIV-associated cognitive impairment: Results from a randomized trialSACKTOR, N; MIYAHARA, S; COOMBS, R. W et al.Neurology. 2011, Vol 77, Num 12, pp 1135-1142, issn 0028-3878, 8 p.Article

Minocycline Protects Dopaminergic Neurons Against Long-Term Rotenone ToxicityRADAD, Khaled; MOLDZIO, Rudolf; RAUSCH, Wolf-Dieter et al.Canadian journal of neurological sciences. 2010, Vol 37, Num 1, pp 81-85, issn 0317-1671, 5 p.Article

Black pigmentation of bone due to long-tern minocycline usePANDIT, S; HADDEN, W.The Surgeon (Edinburgh). 2004, Vol 2, Num 4, pp 236-237, issn 1479-666X, 2 p.Article

Minocycline-induced oral hyperpigmentationEISEN, D.Lancet (British edition). 1997, Vol 349, Num 9049, issn 0140-6736, p. 400Article

No findings of dental defects in children treated with minocyclineCASCIO, Antonio; DI LIBERTO, Chiara; D'ANGELO, Matteo et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 7, pp 2739-2741, issn 0066-4804, 3 p.Article

Minocycline and psychoneuroimmunology in schizophreniaCHAVES, Cristiano; DE MARQUE, Cristiane R; HALLAK, Jaime E. C et al.Progress in neuro-psychopharmacology & biological psychiatry. 2010, Vol 34, Num 6, pp 1133-1134, issn 0278-5846, 2 p.Article

Minocycline-Induced Pigmentation Mimicking Persistent EcchymosisYOUSSEF, Sherry; KIM LANGEVIN, Kathy; YOUNG, Lorraine C et al.Cutis (New York, NY). 2009, Vol 84, Num 1, pp 22-26, issn 0011-4162, 5 p.Article

Minocycline mitigates isoflurane-induced cognitive impairment in aged ratsLI, Shi-Yong; XIA, Li-Xia; ZHAO, Yi-Lin et al.Brain research. 2013, Vol 1496, pp 84-93, issn 0006-8993, 10 p.Article